Furthermore, the up-regulation might be due to the increased number of mast cells secreting VIP in the Peyer’s patches which in turn activates the EGC, and hypothetically this may explain why we find more EGCGFAP+ and EGCS100β+ in Peyer’s patches of CD patients compared to non-IBD controls. Here, VIP is linked to Cowden disease.